(Total Views: 498)
Posted On: 01/14/2021 10:16:55 AM
Post# of 148903
Potential Demand for Leronlimab Rising Every Hour
Article below highlights "Suspected Infections" in Phizer/BioNTech vaccine trials.
This large number was not considering, because the Primary Endpoint was severe and critical hospitalized infections.
3410 cases of "Suspected Infections".... 1594 of those in the vaccine group.
This report implies that many many more folks, who received the Phizer vaccine, will get the virus, yes only mild/moderate, but they will be able to spread the virus.
If we add the future of mutations, the virus is looking even worse. It will very likely be with us forever.
Therapeutics may be considered the first line of defense, the primary line of defense. Maybe daily intake of leronlimab and/or similar treatments, like a Leronlimab daily chewing gum.
https://blogs.bmj.com/bmj/2021/01/04/peter-do...-raw-data/
Article below highlights "Suspected Infections" in Phizer/BioNTech vaccine trials.
This large number was not considering, because the Primary Endpoint was severe and critical hospitalized infections.
3410 cases of "Suspected Infections".... 1594 of those in the vaccine group.
This report implies that many many more folks, who received the Phizer vaccine, will get the virus, yes only mild/moderate, but they will be able to spread the virus.
If we add the future of mutations, the virus is looking even worse. It will very likely be with us forever.
Therapeutics may be considered the first line of defense, the primary line of defense. Maybe daily intake of leronlimab and/or similar treatments, like a Leronlimab daily chewing gum.
https://blogs.bmj.com/bmj/2021/01/04/peter-do...-raw-data/
(2)
(0)Scroll down for more posts ▼
